In this study, we have also described an increase of CD4+c-Met+ T lymphocytes in the peripheral blood of MS patients and demonstrated that this population expressed higher level of Itgα4 compared to CD4+c-Met− counterpart. This evidence concerns the gene CD4 and myeloid sarcoma.